Thomas DesRosier Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Thomas DesRosier.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Thomas DesRosier. Thomas DesRosier is a Sr VP General Counsel in GENZYME CORP ($GENZ) and a EVP, General Counsel in ARIAD PHARMACEUTICALS INC ($ARIA) and a Chief Legal Officer and EVP in Seres Therapeutics, Inc. ($MCRB) and a See Remarks in Seres Therapeutics, Inc. ($MCRB).
Address: GENZYME CORPORATION 500 KENDALL STREET CAMBRIDGE 02142 MA
Companies in which Thomas DesRosier is an Insider
ARIAD PHARMACEUTICALS INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Thomas DesRosier: EVP, General Counsel
Holdings: 36,630 shares
Current Value: $872,160
Latest Transaction: Mar 30 2016
$ARIA Market Capitalization: $4.64B
$ARIA Previous Close: $23.81
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
GENZYME CORP
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Thomas DesRosier: Sr VP General Counsel
Holdings: 716 shares
Latest Transaction: Aug 08 2008
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Seres Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Thomas DesRosier: Chief Legal Officer and EVP, See Remarks
Holdings: 41,054 shares
Current Value: $390,013
Latest Transaction: Feb 08 2021
$MCRB Market Capitalization: $374.90M
$MCRB Previous Close: $9.50
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Thomas DesRosier
Sentiment: All, ARIA, GENZ, MCRB
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 08 2021 | MCRB | Seres Therapeutics ... | DesRosier Thomas | Chief Legal Officer ... | Option Exercise | A | 26.34 | 100,000 | 2,634,000 | 100,000 | |
| Jan 31 2020 | MCRB | Seres Therapeutics ... | DesRosier Thomas | Chief Legal Officer ... | Option Exercise | A | 3.30 | 350,000 | 1,155,000 | 350,000 | |
| Jan 28 2020 | MCRB | Seres Therapeutics ... | DesRosier Thomas | Chief Legal Officer ... | Option Exercise | M | 0.00 | 25,000 | 0 | 0 | |
| Jan 28 2020 | MCRB | Seres Therapeutics ... | DesRosier Thomas | Chief Legal Officer ... | Buy | M | 0.00 | 25,000 | 0 | 41,054 | 16.1 K to 41.1 K (+155.72 %) |
| Jan 29 2019 | MCRB | Seres Therapeutics ... | DesRosier Thomas | Chief Legal Officer ... | Option Exercise | M | 0.00 | 15,000 | 0 | 25,000 | |
| Jan 29 2019 | MCRB | Seres Therapeutics ... | DesRosier Thomas | Chief Legal Officer ... | Option Exercise | A | 6.01 | 84,800 | 509,648 | 84,800 | |
| Jan 29 2019 | MCRB | Seres Therapeutics ... | DesRosier Thomas | Chief Legal Officer ... | Sell | S | 5.75 | 5,471 | 31,478 | 16,054 | 21.5 K to 16.1 K (-25.42 %) |